nodes	percent_of_prediction	percent_of_DWPC	metapath
Bethanechol—CHRM3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0327	0.0327	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0323	0.0323	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Other—P2RY11—narcolepsy	0.0305	0.0305	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.0303	0.0303	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—HTR2A—narcolepsy	0.0194	0.0194	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.0192	0.0192	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0178	0.0178	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0178	0.0178	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—P2RY11—narcolepsy	0.0172	0.0172	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0163	0.0163	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0159	0.0159	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0159	0.0159	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0154	0.0154	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0131	0.0131	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0131	0.0131	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0099	0.0099	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00967	0.00967	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00957	0.00957	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0092	0.0092	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00897	0.00897	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00897	0.00897	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00888	0.00888	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00888	0.00888	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00866	0.00866	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00862	0.00862	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.0086	0.0086	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00857	0.00857	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00853	0.00853	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00852	0.00852	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00804	0.00804	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00804	0.00804	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.008	0.008	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0075	0.0075	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00743	0.00743	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00736	0.00736	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00733	0.00733	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00729	0.00729	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00719	0.00719	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00719	0.00719	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00656	0.00656	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.0065	0.0065	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00643	0.00643	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00636	0.00636	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00558	0.00558	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00554	0.00554	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00553	0.00553	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00532	0.00532	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00532	0.00532	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00502	0.00502	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00502	0.00502	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00489	0.00489	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00489	0.00489	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00485	0.00485	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00485	0.00485	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00456	0.00456	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00456	0.00456	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00444	0.00444	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.0044	0.0044	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00433	0.00433	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00371	0.00371	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0037	0.0037	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CHKB—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00367	0.00367	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00333	0.00333	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00315	0.00315	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CPT1B—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PENK—narcolepsy	0.00199	0.00199	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PENK—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TRH—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NPS—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NPS—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000739	0.000739	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000732	0.000732	CbGpPWpGaD
